|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01833 PA GOODDOCTOR
Nominal 
14.440 -0.200 (-1.366%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 2,093,449 | -5.793% | 4,673,562 | 6,205,082 | 7,334,214 | 6,865,987 |
| Cost of Sales | (1,419,651) | -5.785% | (3,165,049) | (4,533,851) | (5,627,353) | (5,001,573) |
| Gross Profit | 673,798 | -5.810% | 1,508,513 | 1,671,231 | 1,706,861 | 1,864,414 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (268) | -88.903% | 251 | (66,323) | (38,773) | (121,895) | |
| Profit / (Loss) before Taxation | 60,652 | -- | (331,893) | (636,183) | (1,523,607) | (941,348) | |
| Taxation | (23) | -96.192% | (2,965) | (3,410) | (15,792) | (7,155) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (3,981) | -- | 12,264 | 3,535 | 1,216 | 25 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 56,648 | -- | (322,594) | (636,058) | (1,538,183) | (948,478) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (102,436) | -19.544% | (255,193) | (257,939) | (299,631) | (199,160) |
| Depreciation & Amortisation | 52,529 | -38.293% | 160,779 | 190,178 | 206,940 | 169,777 |
| Directors' Emoluments | -- | -- | 30,295 | 26,808 | 28,309 | 14,307 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 5.000 | -- | -30.000 | -59.000 | -139.000 | -92.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.262) | (0.750) | (1.272) | (1.071) |
| NBV per share ($) | 11.958 | -- | 11.873 | 12.095 | 12.275 | 13.800 |
| Remarks: | Real time quote last updated: 21/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 56,648 |
| %Change | -- |
| EPS / (LPS) | RMB 0.050 |
| NBV Per Share (¥) | RMB 11.958 |